2022 annual financial data
Amphastar Pharmaceuticals 2022 Net margin
Amphastar Pharmaceuticals 2022 net margin with verified reported values.
Direct answer
Net margin was 18.31%.
Operating income was 107,497,000 USD and net income was 91,386,000 USD.
Operating cash flow was 89,181,000 USD.
Get free Amphastar Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 498,987,000 USD
- Operating income
- 107,497,000 USD
- Net income
- 91,386,000 USD
- Operating cash flow
- 89,181,000 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Amphastar Pharmaceuticals financial years